Astera Labs, Inc. (NASDAQ:ALAB) Short Interest Up 25.6% in March

Astera Labs, Inc. (NASDAQ:ALAB) was the target of a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 13,516,520 shares, a growth of 25.6% from the February 26th total of 10,763,918 shares. Currently, 9.1% of the shares of the company are short sold. Based on an average trading volume of 4,874,844 shares, the days-to-cover ratio is presently 2.8 days.

Insider Activity

In other news, CEO Jitendra Mohan sold 157,500 shares of the company’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $131.58, for a total value of $20,723,850.00. Following the completion of the sale, the chief executive officer directly owned 4,531,732 shares in the company, valued at $596,285,296.56. This represents a 3.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Sanjay Gajendra sold 94,971 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief operating officer directly owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. This represents a 5.84% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 384,292 shares of company stock worth $48,724,919. Company insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently modified their holdings of ALAB. Vanguard Group Inc. lifted its holdings in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after buying an additional 1,693,918 shares in the last quarter. Atreides Management LP boosted its position in shares of Astera Labs by 2,496.6% during the fourth quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after acquiring an additional 1,549,144 shares during the last quarter. Amundi grew its stake in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC bought a new stake in Astera Labs in the 3rd quarter valued at $209,599,000. Finally, BNP Paribas Financial Markets increased its holdings in Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on ALAB. Barclays set a $165.00 price objective on Astera Labs in a research note on Thursday, January 15th. Northland Securities increased their target price on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a report on Tuesday, December 9th. Citigroup decreased their target price on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, February 11th. Weiss Ratings downgraded shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Finally, Royal Bank Of Canada assumed coverage on shares of Astera Labs in a research report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $202.22.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $112.47 on Monday. The company has a market capitalization of $19.26 billion, a price-to-earnings ratio of 92.19, a PEG ratio of 2.21 and a beta of 1.75. The stock’s 50-day simple moving average is $138.30 and its 200-day simple moving average is $162.90. Astera Labs has a 52 week low of $47.13 and a 52 week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm’s revenue was up 91.8% on a year-over-year basis. During the same quarter last year, the business posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities analysts expect that Astera Labs will post 0.34 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.